Deprescribing of non-antiretroviral therapy in HIV-infected patients.

José-Ramon BlancoRamón MorilloVicente AbrilIsmael EscobarEnrique BernalCarlos FolgueraFátima BrañasMercedes GimenoOlatz IbarraJosé-Antonio IribarrenAlicia LázaroAna MariñoMaría-Teresa MartínEsteban MartinezLuis OrtegaJulian OlallaAguas RobustilloMatilde Sanchez-CondeMiguel-Angel RodriguezJavier de la TorreJavier Sanchez-RubioMontse Tusetnull null

Published in: European journal of clinical pharmacology (2019)

The deprescribing process shared by professionals and patients definitively would improve management of treatment in this population. Because polypharmacy in HIV-infected patients show that a considerable percentage of patients could be candidates for deprescribing, we must understand the importance of deprescribing and that HIV-infected persons should be a priority group. This process would be highly feasible and effective in HIV-infected persons.

Keyphrases

antiretroviral therapy
hiv infected patients
hiv infected
human immunodeficiency virus
end stage renal disease
hiv positive
hiv aids
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
emergency department